News Press Releases

Glancy Prongay & Murray LLP Continues Investigation on Behalf of TransDigm Group Incorporated Investors (TDG)

TDG | September 22, 2017

Glancy Prongay & Murray LLP Continues Investigation on Behalf of TransDigm Group Incorporated Investors (TDG)

Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of TransDigm Group Incorporated (“TransDigm” or the “Company”) (NYSE: TDG) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the TransDigm page on our website at www.glancylaw.com/case/transdigm-group-inc.

On January 20, 2017, Citron Research issued a report accusing TransDigm of being the “Valeant of the aerospace industry.” The report claimed that the Company uses multiple shell distributors that have no pricing power to make government bids seem competitive. Citron further emphasized that TransDigm’s growth was driven, in large part, by rampant acquisitions and extreme debt levels.

On this news, TransDigm’s share price fell $24.86 per share, or 9.87%, from $251.76 per share on January 19, 2017 to $226.90 per share on January 20, 2017, thereby damaging investors.

Then, on March 21, 2017, California Representative Ro Khanna sent a letter to the Defense Department Inspector General asking for an investigation into the business practices of TransDigm, claiming that the Company appears to be evading certain pricing and cost disclosure regulations. On this news, the Company’s share price declined by more than 5%, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased TransDigm securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.